Dow Up 0.51% Nasdaq Up 0.24%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.88 Up 0.12(2.08%) Nov 21, 4:00PM EST
|After Hours : 5.84 Down 0.04 (0.68%) Nov 21, 7:50PM EST
Prev Close:5.76
Open:5.93
Bid:N/A
Ask:6.19 x 4000
1y Target Est:11.33
Beta:3.84
Next Earnings Date:N/A
Day's Range:5.77 - 6.04
52wk Range:3.11 - 7.82
Volume:4,637,556
Avg Vol (3m):4,587,330
Market Cap:724.22M
P/E (ttm):N/A
EPS (ttm):-0.53
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXUp 2.08%724.22M
ABTUp 0.07%65.97B
GSKUp 0.04%111.55B
RHHBYDown 1.04%253.38B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Dec-14) :0.23
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-3.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback